产品
编 号:F171164
分子式:C45H58N10O9S2
分子量:947.13
产品类型
结构图
CAS No: 147159-51-1
联系客服
产品详情
生物活性:
TT-232 (CAP-232), a somatostatin derivative, is a peptide SSTR1/SSTR4 agonist. TT-232 inhibits cancer cell proliferation and induces apoptosis. TT-232 is also a broad-spectrum anti-inflammatory and analgesic agent.
体内研究:
TT-232 (15-750 μg/kg/day, twice a day) inhibits tumor growth in mice transplanted with Colon 26 cell.TT-232 (0.6 or 15 μg/kg s.c or i.p.) shows antitumor effect on P-388 rodent lymphocytic leukemia tumor mice.TT-232 (7.5-20 μg/kg, i.v.) inhibits Carrageenin-induced paw oedema in rats.Animal Model:Mice transplanted with Colon 26 cell .
Dosage:15, 150, 750 μg/kg/day
Administration:Intraperitoneal injection (i.p.)
Result:Reached 70% tumor inhibition at 750 μg/kg.
体外研究:
TT-232 (10 μg/mL, 48 h) induces apoptosis in human colon (HT-29 and SW620), pancreatic (818), leukemia (K-562), melanoma (WM 938/B, M-1 and EP) and lymphoma (HT-58) tumor cell lines.TT-232 (20-30 μg/mL, 24 h) shows antiproliferative effect on various human tumor cell lines.